Vaccitech PLC
F:2AB

Watchlist Manager
Vaccitech PLC Logo
Vaccitech PLC
F:2AB
Watchlist
Price: 0.58 EUR -1.69% Market Closed
Market Cap: 22.6m EUR

Net Margin
Vaccitech PLC

0%
Current
-2 759%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-54.8m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Vaccitech PLC
Glance View

Market Cap
23.7m EUR
Industry
Biotechnology

Vaccitech Plc operates as a holding company. The company is headquartered in Oxford, Oxfordshire and currently employs 72 full-time employees. The company went IPO on 2021-04-30. The firm is engaged in the discovery and development of immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The firm uses its platform to develop product candidates that target immune responses against pathogens and tumor cells. The firm has a pipeline of both clinical and preclinical stage therapeutic and prophylactic programs. Its therapeutic programs include VTP-300 for the treatment of chronic hepatitis B infection (CHB), VTP-200 for the treatment of human papilloma virus infection (HPV), VTP-850 for the treatment of prostate cancer and VTP-600 for the treatment of non-small cell lung cancer (NSCLC). Its prophylactic programs include VTP-400 for the prevention of herpes zoster (shingles), and VTP-500 for the prevention of the Middle East respiratory syndrome (MERS).

2AB Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-54.8m
/
Revenue
0
What is the Net Margin of Vaccitech PLC?

Based on Vaccitech PLC's most recent financial statements, the company has Net Margin of 0%.

Back to Top